US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Goldman Sachs Group
(NY:
GS
)
902.56
+5.89 (+0.66%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Goldman Sachs Group
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Is Walmart a Millionaire-Maker Stock?
↗
June 10, 2026
What comes next for the iconic big box retailer?
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead
↗
June 10, 2026
CG Oncology (NASDAQ:CGON) Chief Executive Officer Arthur outlined the company’s upcoming clinical and regulatory milestones for cretostimogene during a presentation at the Goldman Sachs Global...
Via
MarketBeat
Topics
Initial Public Offering
Why Signet Jewelers Stock Triumphed on Tuesday
↗
June 09, 2026
It announced a $50 million accelerated share repurchase program.
Via
The Motley Fool
The SpaceX IPO Is Days Away. Here's How to Prepare.
↗
June 09, 2026
SpaceX is hoping to raise $75 billion at a $1.77 trillion valuation.
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
Goldman Sachs Just Made a Bold Statement About SpaceX. Here's Why I'm Not Buying It
↗
June 09, 2026
Things would have to go perfectly for the next half-decade.
Via
The Motley Fool
Topics
Artificial Intelligence
Expro, NESR, and Nabors Industries Stocks Trade Down, What You Need To Know
June 09, 2026
What Happened? A number of stocks fell in the afternoon session after Trump said a US-Iran deal could come in "two or three days," pulling energy equities sh...
Via
StockStory
Topics
Government
Tuesday's session: top gainers and losers in the dow jones index
↗
June 09, 2026
Via
Chartmill
Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase
↗
June 09, 2026
Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics...
Via
MarketBeat
Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts
↗
June 09, 2026
Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst...
Via
MarketBeat
Stay informed with the top movers within the dow jones index on Tuesday.
↗
June 09, 2026
Via
Chartmill
Option Care Health (OPCH) Stock Trades Up, Here Is Why
June 09, 2026
What Happened? Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 3.7% in the morning session after Goldman Sachs initiated cov...
Via
StockStory
Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure
↗
June 09, 2026
Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for...
Via
MarketBeat
Topics
ETFs
Intellectual Property
Citi, Goldman Stay Bullish on Copper Amid Ongoing Supply Pressures
June 09, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead
↗
June 09, 2026
Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the...
Via
MarketBeat
From SaaS to AaaS: How Tec-Do's Multi-Agent Infrastructure is Shaping the Future of MarTech
June 09, 2026
Via
GlobePRwire
Topics
Artificial Intelligence
ETFs
GS Stock Trades Near $1,045 After June 2026 Market Session
↗
June 09, 2026
Goldman Sachs stayed in focus as GS stock traded near $1,045 on June 9, 2026, after another active market session. The stock was recently priced at $1,045.
Via
Talk Markets
Topics
Earnings
Prediction: June 12 Will be a Huge Day for the Stock Market
↗
June 09, 2026
Investors are being offered a new AI investment opportunity.
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls
↗
June 08, 2026
Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering...
Via
MarketBeat
Topics
Initial Public Offering
Could Investing in the SpaceX IPO Set You Up for Life? History Offers an Answer That's Crystal Clear.
↗
June 08, 2026
SpaceX says it may serve a $28 trillion market.
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
Why Is Oscar Health (OSCR) Stock Rocketing Higher Today
June 08, 2026
What Happened? Shares of health insurance company Oscar Health (NYSE:OSCR) jumped 10.8% in the afternoon session after the company provided a business update...
Via
StockStory
Topics
Artificial Intelligence
Exploring the top movers within the dow jones index during today's session.
↗
June 08, 2026
Via
Chartmill
Nasdaq and S&P 500 Bounce Back On Monday as Chip Stocks Shake Off Friday's Hangover
↗
June 08, 2026
Semiconductor stocks are staging a comeback on Monday. Here's what's driving the rebound in Intel, Micron, and the broader market.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Stocks
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead
↗
June 08, 2026
Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming...
Via
MarketBeat
Uncover the latest developments among dow jones stocks in today's session.
↗
June 08, 2026
Via
Chartmill
VOO vs. RSP: Which S&P 500 ETF Is Better?
↗
June 08, 2026
Choosing between these two S&P 500 ETFs really comes down to how you feel about the tech sector.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Why Peloton Stock Zoomed More Than 17% Higher Last Month
↗
June 08, 2026
It flipped into the black on the bottom line in its latest reported quarter.
Via
The Motley Fool
Is VEA the Smartest Investment You Can Make Right Now?
↗
June 07, 2026
Your best long-term investment may not include U.S. stocks.
Via
The Motley Fool
Topics
ETFs
Investment Banks Keep Raising Their Price Target on This Rare-Earth Mining Stock. Time to Buy?
↗
June 07, 2026
The United States is taking a strong approach to reshoring the mining and processing of rare-earth elements, and MP Materials is one of the top beneficiaries.
Via
The Motley Fool
The IPO Market Is Heating Up Again. These Financial Stocks Stand to Win.
↗
June 07, 2026
Animal spirits are running high as private companies like SpaceX and OpenAI look to go public.
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
2 Stocks That Win No Matter What Happens to SpaceX After Its IPO
↗
June 07, 2026
The SpaceX IPO is going to be huge, but no one knows what the stock will do once it's public.
Via
The Motley Fool
Topics
Initial Public Offering
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
